InvestorsHub Logo
Followers 20
Posts 1059
Boards Moderated 0
Alias Born 04/01/2013

Re: exwannabe post# 16361

Friday, 10/11/2013 1:57:01 PM

Friday, October 11, 2013 1:57:01 PM

Post# of 427762
Yes, they need to discuss Reduce it, since it was in the SPA its not a huge surprise. There were no surprises in terms of negative side effects, anything to do with efficacy.

The JELIS trial points to efficacy with EPA, we on these message boards know the science as to why it works and these other studies that have failed and AMRN will also have this info and can pass that along to the committee..

Again with zero side effects, the JELIS study and science along with the substantially underway they will get a positive vote and near unanimous.

The selling related to mentioning of REDUCE IT is crazy. Crazy I tell you.



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News